Shareholding disclosure

Credit Suisse Funds AG

Declared position

9.48%

Threshold

Crossed upwards

Timeline

Published

24.01.2019

Transaction

19.12.2018

Voting rights breakdown

Voting rights acquired9.48%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ1L00040

Beneficial owner

Credit Suisse Funds AG

Declared address

Credit Suisse Funds AG, Zurich

Kapitalerhöhung im Zusammenhang mit Zeichnung von neuen Aktien

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Credit Suisse Funds AG

Kuros Biosciences AG24.01.2019TAJ1L00040

Disclosure summary

Credit Suisse Funds AG disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 24.01.2019, at 9.48% of voting rights. Notice category: Single shareholder.

Disclosed position

9.48%

Voting rights acquired

Voting rights acquired9.48%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Credit Suisse Funds AG disclosed a holding in Kuros Biosciences AG, published on 24.01.2019.

Publication date24.01.2019

Transaction date19.12.2018

Issuing companyKuros Biosciences AG

Beneficial ownerCredit Suisse Funds AG

Declared addressCredit Suisse Funds AG, Zurich

CategorySingle shareholder

Voting rights acquired9.48%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAJ1L00040

Commercial register

CHE-102.923.465

Struck off the register · 03.05.2024

Zefix record

Conditions

Kapitalerhöhung im Zusammenhang mit Zeichnung von neuen Aktien

Source: SIX Exchange Regulation · Publication date: 24.01.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open